Richard G. Ghalie
2022
In 2022, Richard G. Ghalie earned a total compensation of $1.2M as Chief Medical Officer at MEI Pharma, a 1% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $118,528 |
|---|---|
| Option Awards | $575,200 |
| Salary | $463,000 |
| Total | $1,156,728 |
Ghalie received $575.2K in option awards, accounting for 50% of the total pay in 2022.
Ghalie also received $118.5K in non-equity incentive plan and $463K in salary.
Rankings
In 2022, Richard G. Ghalie's compensation ranked 2,703rd out of 5,501 executives tracked by ExecPay. In other words, Ghalie earned more than 50.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,703 out of 5,501 | 51st |
Division Manufacturing | 1,496 out of 2,980 | 50th |
Major group Chemicals And Allied Products | 687 out of 1,335 | 49th |
Industry group Drugs | 639 out of 1,238 | 48th |
Industry Pharmaceutical Preparations | 457 out of 892 | 49th |
Source: SEC filing on October 27, 2022.
Ghalie's colleagues
We found three more compensation records of executives who worked with Richard G. Ghalie at MEI Pharma in 2022.